Drug Profile
Hepatocyte growth factor/scatter factor
Alternative Names: HGF/SFLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator National Cancer Institute (USA)
- Class
- Mechanism of Action Angiogenesis inducing agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Apr 2003 No development reported - Preclinical for Cancer in USA (unspecified route)
- 20 Jul 2001 This compound is still in active development
- 27 Feb 1997 New profile